This tag is associated with 3 posts

IHS @ ISPOR – Please Visit Us at Booth #22

The IHS Global Insight Healthcare and Pharma service is pleased to announce that we will again have a strong presence at the Annual European Congress of ISPOR, Berlin, 2-7 November. Come by booth #22 to meet members of our team and learn about our products and latest research. We will have a total of 7 … Continue reading

Blurring the Boundaries Between Regulatory and HTA Agencies: A Risk-Benefit Analysis

A few weeks ago, I attended the 9th annual HTAi meeting in Bilbao, Spain, where there were a few sessions on, and a lot of debate over, the “interface between regulatory and HTA processes.” There seemed to be a consensus among the audience that, in future, there will be increased alignment between the regulatory and … Continue reading

Relative Effectiveness Assessments (REA) of Pharmaceuticals — The Latest Key to Market Access and Price Premiums

With the introduction of AMNOG early last year, Germany jumped on the relative effectiveness assessment (REA) bandwagon by linking pharmaceutical prices to added therapeutic benefit scores. Later in the year, France passed legislation that allows the national regulator to request comparative clinical data when evaluating a medicine for marketing authorisation. The country intends to take … Continue reading

Enter your email address to follow this blog and receive notifications of new posts by email.

Download extract from IHS Flexible Pricing strategies multi client study
Drug Price Erosion Multi Client Study extract download

About This Blog

In this blog, our experts share regular insights on the global life sciences industry. Join us as we look at issues in healthcare policy, market access, pricing and reimbursement and R&D. Comments are welcome!
40 countries covered. Download a sample chapter on Brazil
Download a complimentary white paper on market-access risk ratings
Download a sample of the primary research and analysis on French P&R reform

Follow IHS Life Sciences on Twitter


Get every new post delivered to your Inbox.

Join 347 other followers